The Structure, Pathogenesis, and Inhibition of the p53-MDM2 Pathway
Cancers · 07.02.2026 · 18 (4) · 546
DOI: 10.3390/cancers18040546 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 07.02.2026. Verfasst von Amanda L Brown und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of South Carolina, Columbia, SC 29209, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation.
Abstract (Originalsprache)
The p53 tumor suppressor protein plays a central role in maintaining genomic stability by regulating cell cycle arrest, apoptosis, and DNA repair under cellular stress. Mouse double minute 2 (MDM2), an E3 ubiquitin ligase, negatively regulates p53 via direct binding and proteasomal degradation. Overexpression or amplification of MDM2 can disrupt this pathway and promote tumorigenesis, even in cancers with wild-type p53. This review outlines the structural features of MDM2, particularly its N-terminal hydrophobic pocket and C-terminal RING domain, and their roles in p53 regulation. We further examine the pathological effects of MDM2 dysregulation and SNPs linked to increased cancer risk. Recent progress in small molecule MDM2 inhibitors is discussed, with a focus on non-covalent agents such as rhein-derived anthraquinone analogs, including AQ-101, which demonstrate promising anti-cancer activity with reduced toxicity. These findings support the continued development of non-covalent MDM2 inhibitors as a novel therapeutic approach for cancers involving both wild-type and mutant p53.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
- Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA.
ORCID-Profile: Amanda L Brown
Förderung
- National Science Foundation
Zitieren
APA
Brown, A. L., Lian, X., & Wang, Q. (2026). The Structure, Pathogenesis, and Inhibition of the p53-MDM2 Pathway. Cancers, 18(4), 546. https://doi.org/10.3390/cancers18040546
Vancouver
Brown AL, Lian X, Wang Q. The Structure, Pathogenesis, and Inhibition of the p53-MDM2 Pathway. Cancers. 2026;18(4):546. doi:10.3390/cancers18040546
BibTeX
@article{Brown2026,
author = {Brown, Amanda L and Lian, Xiaoying and Wang, Qian},
title = {The Structure, Pathogenesis, and Inhibition of the p53-MDM2 Pathway},
journal = {Cancers},
year = {2026},
volume = {18},
number = {4},
pages = {546},
doi = {10.3390/cancers18040546}
}
EUVIMED